IP Library › Granted Patent US 12,324,736
Granted Patent B2
US 12,324,736 · App. 18/368,541 · Granted Jun 10, 2025

Stented prosthetic heart valve with variable stiffness and methods of use

Inventors: Rodney Bell (Galway, IE); Declan Costello (Galway, IE)
Assignee: MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
A61F2/2418A61F2250/0018A61F2250/0029
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,324,736
App. No.
18/368,541
Granted
Jun 10, 2025
Kind
B2
Abstract

A prosthetic heart valve including a stent frame and a valve structure. The valve structure is disposed within a lumen of the stent frame. The stent frame is configured to self-expand from a compressed condition for transluminal delivery. The stent frame has a lattice structure forming a tubular shape defining a circumference and a plurality of closed cells arranged to define a band exhibiting a variable radial stiffness. The prosthesis can be deployed such that the band applies a minimal force on to anatomical locations relating to the heart's conductive pathways. A region of the band otherwise having low radial stiffness is located at or over a conductive pathway upon final implant.

Claims (23)

1. A method of treating a native heart valve of a patient, the method comprising:

delivering a prosthetic heart valve to the native heart valve with a delivery device, the prosthetic heart valve including a stent frame maintaining a valve structure, the stent frame configured to expand from a compressed condition to a natural, expanded condition, the stent frame comprising a lattice structure defining at least a first band of closed cells extending about an entirety of a circumference of the stent frame, wherein the first band defines a first region and a second region and is configured to have a variable radial stiffness along the circumference in the natural, expanded condition;

at least partially deploying the prosthetic heart valve from the delivery device into the native heart valve, including the stent frame self-expanding toward the natural, expanded condition; and

aligning the first region with a conductive pathway of the native heart valve.

2. The method of claim 1 , wherein the first region comprises a maximum radial stiffness less than a minimum radial stiffness of the second region.

3. The method of claim 1 , wherein aligning includes aligning a radiopaque marker of the stent frame with a native commissure of the native heart valve.

4. The method of claim 1 , wherein the conductive pathway is one of conduction fibers of a left ventricular septum, SA node, and bundle of His.

5. The method of claim 1 , wherein each of the closed cells of the first band are uniformly spaced along the circumference.

6. The method of claim 1 , wherein the valve structure includes a plurality of leaflets arranged to define an inflow side and an outflow side, and further wherein the first band is located proximate the inflow side.

7. The method of claim 1 , wherein an arc angle of the first region is less than an arc angle of the second region.

8. The method of claim 1 , wherein each of the closed cells includes a plurality of interconnected struts, and further wherein a geometry of at least one of the struts of the closed cells of the first region is less than a corresponding geometry of a corresponding strut of the closed cells of the second region.

9. The method of claim 8 , wherein the geometry is at least one of a length and a width of a segment of the strut.

10. The method of claim 8 , wherein at least one of the struts at the first region is tapered resulting in a variance in mass of the tapered strut as compared to struts at the second region.

11. The method of claim 1 , wherein the first band further includes a joint connector connecting immediately circumferentially adjacent ones of the closed cells to one another, and further wherein a geometry of each of the joint connectors of the first region is less than a corresponding geometry of each of the joint connectors of the second region.

12. The method of claim 1 , wherein the closed cells are arranged to further define a second band of closed cells extending about an entirety of the circumference, the second band being immediately longitudinally adjacent the first band, and further wherein the second band is configured to have a variable radial stiffness along the circumference in the natural, expanded condition.

13. The method of claim 12 , wherein the first and second bands collectively define a low radial stiffness region.

14. The method of claim 1 , wherein the closed cells are formed by struts and interconnected with nodes extending between adjacent cells, and further wherein the nodes of the first band are configured to have a variance in mass to result in a variable radial stiffness along the circumference in the natural, expanded condition.

15. A method of treating a native heart valve of a patient, the method comprising:

delivering a prosthetic heart valve to the native heart valve with a delivery device, the prosthetic heart valve including a stent frame maintaining a valve structure, the stent frame configured to expand from a compressed condition to a natural, expanded condition, the stent frame comprising a lattice structure defining at least a first band of closed cells extending about an entirety of a circumference of the stent frame, wherein the first band is configured to have a variable stiffness along the circumference in the natural, expanded condition, the stent frame further including a radiopaque marker;

at least partially deploying the prosthetic heart valve from the delivery device into the native heart valve, including the stent frame self-expanding toward the natural, expanded condition; and

aligning the radiopaque marker with a desired anatomical location of the native heart valve.

16. The method of claim 15 , wherein the radiopaque marker is aligned with a commissure of the native heart valve.

17. The method of claim 15 , wherein each of the closed cells of the first band are uniformly spaced along the circumference.

Assignments (2)
CHANGE OF NAME Recorded Mar 12, 2025
From: MEDTRONIC VASCULAR GALWAY
To: MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Reel/Frame 070485/0985 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2023
From: BELL, RODNEY; COSTELLO, DECLAN
To: MEDTRONIC VASCULAR GALWAY
Reel/Frame 064916/0265 →
Continuity (5)
Continuation 17845222 · Jun 21, 2022
Continuation 16898674 · Jun 11, 2020
Division 15665998 · Aug 1, 2017
Division 14164301 · Jan 27, 2014
Related Publication 20240000564A1 · Jan 4, 2024
References Cited (117)
US 3657744A · Ersek · 1972 [cited by applicant]
US 5836966A · St. Germain · 1998 [cited by examiner]
US 5938697A · Killion · 1999 [cited by examiner]
US 6027526A · Limon et al. · 2000 [cited by applicant]
US 6468302B2 · Cox · 2002 [cited by examiner]
US 6602281B1 · Klein · 2003 [cited by applicant]
US 6613074B1 · Mitelberg et al. · 2003 [cited by applicant]
US 6790230B2 · Beyerdorf et al. · 2004 [cited by applicant]
US 6899729B1 · Cox · 2005 [cited by examiner]
US 7018406B2 · Seguin · 2006 [cited by applicant]
US 7252682B2 · Seguin · 2007 [cited by applicant]
US 7258697B1 · Cox · 2007 [cited by examiner]
US 7470285B2 · Nugent et al. · 2008 [cited by applicant]
US 7637937B2 · Case · 2009 [cited by examiner]
US 7857845B2 · Stacchino et al. · 2010 [cited by applicant]
US 8414645B2 · Dwork · 2013 [cited by examiner]
US 9180005B1 · Lashinski et al. · 2015 [cited by applicant]
US 9259336B2 · Schaeffer et al. · 2016 [cited by applicant]
US 9750603B2 · Bell · 2017 [cited by examiner]
US 10271977B2 · Longo · 2019 [cited by examiner]
US 10321994B2 · Erzberger · 2019 [cited by applicant]
US 10441447B2 · Krieger · 2019 [cited by examiner]
US 10470880B2 · Braido · 2019 [cited by applicant]
US 10857413B2 · Hetrick · 2020 [cited by examiner]
US 10881541B1 · Rocha-Singh · 2021 [cited by examiner]
US 11090153B2 · Haarer et al. · 2021 [cited by applicant]
US 11197754B2 · Saffari et al. · 2021 [cited by applicant]
US 20030135265A1 · Stinson · 2003 [cited by applicant]
US 20040034402A1 · Bales · 2004 [cited by applicant]
US 20040210304A1 · Seguin et al. · 2004 [cited by applicant]
US 20040243216A1 · Gregorich et al. · 2004 [cited by applicant]
US 20060100690A1 · Venturelli · 2006 [cited by applicant]
US 20060122692A1 · Gilad · 2006 [cited by applicant]
US 20060173531A1 · Richter · 2006 [cited by applicant]
US 20060200227A1 · Jang · 2006 [cited by applicant]
US 20060265056A1 · Nguyen · 2006 [cited by applicant]
US 20080140189A1 · Nguyen · 2008 [cited by applicant]
US 20080167707A1 · Marrey · 2008 [cited by examiner]
US 20090287296A1 · Manasse · 2009 [cited by applicant]
US 20100094391A1 · Heraty · 2010 [cited by examiner]
US 20110022157A1 · Essinger et al. · 2011 [cited by applicant]
US 20110098804A1 · Yeung · 2011 [cited by examiner]
US 20110112626A1 · Van der Leest · 2011 [cited by applicant]
US 20110251680A1 · Tran · 2011 [cited by applicant]
US 20110264196A1 · Savage · 2011 [cited by applicant]
US 20120071969A1 · Li · 2012 [cited by applicant]
US 20120101572A1 · Kovalsky · 2012 [cited by examiner]
US 20120116496A1 · Chuter · 2012 [cited by applicant]
US 20120116498A1 · Chuter · 2012 [cited by examiner]
US 20120123529A1 · Levi et al. · 2012 [cited by applicant]
US 20120143316A1 · Seguin · 2012 [cited by applicant]
US 20130178928A1 · Vyas · 2013 [cited by examiner]
US 20130261739A1 · Kuehn · 2013 [cited by applicant]
US 20130282113A1 · Punga · 2013 [cited by examiner]
US 20130338766A1 · Hastings et al. · 2013 [cited by applicant]
US 20140000112A1 · Braido · 2014 [cited by applicant]
US 20140025157A1 · Abunassar · 2014 [cited by applicant]
US 20140107767A1 · Braido · 2014 [cited by applicant]
US 20140114408A1 · Dwork · 2014 [cited by applicant]
US 20140200660A1 · Savage et al. · 2014 [cited by applicant]
US 20140214157A1 · Bortlein · 2014 [cited by applicant]
US 20140277412A1 · Bortlein · 2014 [cited by applicant]
US 20150209140A1 · Bell · 2015 [cited by applicant]
US 20150265438A1 · Hossainy et al. · 2015 [cited by applicant]
US 20150320556A1 · Levi et al. · 2015 [cited by applicant]
US 20160015539A1 · Donovan et al. · 2016 [cited by applicant]
US 20160106537A1 · Christianson et al. · 2016 [cited by applicant]
US 20160120646A1 · Dwork · 2016 [cited by applicant]
US 20160200035A1 · Jacobs · 2016 [cited by examiner]
US 20160270910A1 · Birmingham · 2016 [cited by applicant]
US 20170325946A1 · Bell et al. · 2017 [cited by applicant]
US 20190224008A1 · Bressloff · 2019 [cited by applicant]
US 20190247209A1 · Longo · 2019 [cited by examiner]
US 20200297484A1 · Bell et al. · 2020 [cited by applicant]
US 20200345498A1 · Poucher et al. · 2020 [cited by applicant]
US 20210298896A1 · Pham et al. · 2021 [cited by applicant]
US 20210386566A1 · Sreedharan et al. · 2021 [cited by applicant]
US 20220054260A1 · Koop et al. · 2022 [cited by applicant]
US 20220142777A1 · Scheinblum et al. · 2022 [cited by applicant]
US 20220401207A1 · Zavattieri et al. · 2022 [cited by applicant]
US 20230063142A1 · O'Connor et al. · 2023 [cited by applicant]
EP 1941848 · 2008 [cited by applicant]
PCT/US2015/010754, The International Search Report and The Written Opinion of the International Searching Authority, mailed Apr. 8, 2015. [cited by applicant]
CN Application No. 201580005926.2, 1 [cited by applicant]
Till, J.A. et al., “Histopathological findings in three children with His bundle tachycardia occurring subsequent to cardiac surgery,” European Heart Journal, 13, pp. 709-712 (1992). [cited by applicant]
Van der Boon, Robert M. et al., “New conduction abnormalities after TAVI-frequency and causes,” Nature Reviews Cardiology, vol. 9, pp. 454-463 (Aug. 2012). [cited by applicant]
Aktug, Omer et al., “Incidence and predictors of left bundle branch block after transcatheter aortic valve implantation,” Int J Cardiol, pp. 1-5 (2012). [cited by applicant]
Piazza, Nicolo et al., “Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation,” EuroIntervention, pp. 475-484 (2010). [cited by applicant]
Rubin, Joes M. et al. “Atrioventricular Conduction Disturbance Characterization in Transcatheter Aortic Valve Implantation with the CoreValve Prosthesis,” Circ Cardiovasc Interv, pp. 280-286 (2011). [cited by applicant]
Nuis, Rutger-Jan et al., “Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreValve System in patients with aortic stenosis,” European Heart Journal, pp. 1-8 (201… [cited by applicant]
Nuis, RJ et al., “Timing and Potential Mechanisms of New Conduction Abnormalities During the Implantation of a Medtronic CoreValve System in Patients with Aortic Stenosis,” Euro PCR, pp. 1-39 (2011). [cited by applicant]
Grube, Eberhard et al., “Feasibility of Transcatheter Aortic Valve Implantation Without Balloon Pre-Dilation: A Pilot Study,” JACC Cardiovascular Intervention, vol. 4, No. 7, pp. 751-757 (2011). [cited by applicant]
Schroeter, Thomas et al., “Predictors of permanent pacemaker implantation after Medtronic CoreValve bioprosthesis implantation,” European Society of Cardiology, pp. 1-5 (2012). [cited by applicant]
van der Boon, Robert M.A. et al., “Pacemaker dependency after transcatheter aortic valve implantation with the self-expanding Medtronic CoreValve System,” International Journal of Cardiology, pp. 1-5, (2013) <http://dx.… [cited by applicant]
Piazza, Nicole et al., “Anatomy of the Aortic Valvar Complex and Its Implications for Transcatheter Implantation of the Aortic Valve,” Circulation Cardiovascular Interventions, Journal of the American Heart Association,… [cited by applicant]
Kim, Won-Jang, “Can we Prevent AV Block after CoreValve Implantation?” University of Ulsan College of Medicine, ASAN Medical Center, Cardio Vascular Research Foundation, Presentation given at TCT AP, pp. 1-45 (2013). [cited by applicant]
Binder, Ronald K. et al., “Impact of Post-Implant SAPIEN XT Geometry and Position on Conduction Disturbances, Hemodynamic Performance, and Paravalvular Regurgitation,” JACC Cardiovascular Interventions, vol. 6, No. 5, p… [cited by applicant]
Modine, T., “Conduction abnormalities and TAVI: What do we need to know, ” Centre Hospitalier Regional, Universitaire de Lille, pp. 1-36 (Feb. 2013). [cited by applicant]
Petronio, A.S., “Case Report Session, Cardiac Disturbances Prevention,” University of Pisa, pp. 1-30 (Feb. 27, 2013). [cited by applicant]
Roten, Laurent et al., “Atrioventricular Conduction After Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement,” Journal of Cardiovascular Electrophysiology, pp. 1-8 (Apr. 2, 2012). [cited by applicant]
Biner, Simon et al., “Hemodynamic Impact and Outcome of Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Implantation,” The American Journal of Cardiology, pp. 1-6 (2013). [cited by applicant]
Buellesfeld, Lutz, et al., “Impact of Permanent Pacemaker Implantation on Clinical Outcome Among Patients Undergoing Transcatheter Aortic Valve Implantation,” Journal of the American College of Cardiology, pp. 1-9 (2012… [cited by applicant]
Cheong, Dr. Adrian, “Implantation depth and conduction disturbances using the self-expanding TAVI prosthesis,” Prince of Wales Hospital, The Chinese University of Hong Kong, pp. 1-31 (2013). [cited by applicant]
Houthuizen, Patrick et al., “Left Bundle Branch Blocked Inducted by Transcatheter Aortic Valve Implantation Increases Risk of Death,” Circulation, Journal of the American Heart Association, pp. 1-28 (Jul. 12, 2012). [cited by applicant]
Staubach, Stephen et al., “Original Studies. Impact of Aortic Valve Calcification on the Outcome of Transcatheter Aortic Valve Implantation: Results from the Prospective Multicenter German TAVI Registry,” Wiley Periodic… [cited by applicant]
Hoffmann, Rainer et al., “Impact of a New Conduction Defect After Transcatheter Aortic Valve Implantation on Left Ventricular Function,” JACC: Cardiovascular Interventions, by the American College of Cardiology Foundati… [cited by applicant]
Igawa, Osamu et al., “OE-328, The Useful Anatomical Information for Catheter Ablation Concerning the Relationship between the Aortic Non-coronary Cusp and the His Bundle,” Circulation Journal, vol. 73, Suppl. I, pp. 257… [cited by applicant]
Dodge-Khatami, A. et al., “Impact of junctional ectopic tachycardia on postoperative morbidity following repair of congenital heart defects,” European Journal of Cardio-thoracic Surgery, vol. 21, pp. 255-259 (2002). [cited by applicant]
Muller, David et al., “Impact of New Left Bundle Branch Block or Pacemaker Implantation on Outcomes Following Transcatheter Aortic Vavle Implantation in the CoreValve Australia New Zealand Study,” Euro PCR, pp. 1-18 (20… [cited by applicant]
Neragi-Miandoab, Siyamek, et al., “Review Article, A Review of Most Relevant Complications of Transcatheter Aortic Valve Implantation,” Hindawi Publishing Corporation, vol. 2013, pp. 1-13 (2013). [cited by applicant]
Piazza, Nicolo et al., “Early and Persistent Intraventricular Conduction Abnormalities and Requirements for Pacemaking After Percutaneous Replacement of the Aortic Valve,” JACC: Cardiovascular Interventions, The America… [cited by applicant]
Roten, Laurent et al., “Incidence and Predictors of Atrioventricular Conduction Impairment and Need for Permanent Pacemaker After Transcatheter Aortic Valve Implantation,” Inselspital, Bern University Hospital, Switzerl… [cited by applicant]
Saji, Mike et al., “Autopsy finding of the Sapien XT valve from a patient who died suddenly after transcatheter aortic valve replacement,” Japanese Associate of Cardiovascular Intervention and Therapeutics, pp. 1-5 (Jan… [cited by applicant]
Testa, Luca et al., “Clinical Impact of Persistent Left Bundle Branch Block after Transcatheter Aortic Valve Implantation with CoreValue Revalving System,” Circulation, Journal of the American Heart Association, pp. 1-2… [cited by applicant]
Toggweiler, Stefan et al., “Challenges in transcatheter aortic valve implantation,” Swiss Medical Weekly, The European Journal of Medical Sciences, pp. 1-15 (2012). [cited by applicant]
Wenaweser, Peter et al., “Impact of Conduction Disturbances Post Transcatheter Aortic Valve Implantation in Real World Patients: One Year Outcomes, the Advance Study,” Euro PCR, pp. 1-18 (2013). [cited by applicant]
Wolff, Rafael et al., “Low rate of conduction disturbances and the need of permanent pacemaker after transcatheter aortic valve implantation with the core-value bioprosthesis,” Sunnybrook Health Sciences Centre, pp. 1-1… [cited by applicant]